Discontinuation of highly active antiretroviral therapy among Ugandans

Discontinuation of, or outright defaulting on highly active antiretroviral therapy (HAART) by HIV-positive patients is harmful, and so is periodic unintentional non-adherence or treatment interruption. The resulting harm is especially more pronounced in sub-Saharan Africa where most individuals start HAART in advanced stages of the disease. Discontinuing patients could spread drug resistant virus to other individuals.